The Team

Peter copy.jpg

PETER RANDS

MANAGING DIRECTOR

Peter graduated from Oxford in 2003 with a first class degree in Chemistry. After completing an MSc in Chemistry at UCL, Peter trained and qualified as a UK and European patent attorney specializing in pharmaceuticals. Peter founded Small Pharma Ltd in January 2015.

Zelah copy.jpg

ZELAH JOEL

RESEARCH MANAGER

Zelah graduated from UCL in 2010 with a first class honours degree in Biomedical Sciences with a focus on neuroscience and pharmacology. She continued her studies at UCL, completing a PhD in Neuroscience in autumn 2015. Zelah joined Small Pharma in 2016.

Hilary copy.jpg

HILARY WARD

IP MANAGER

Hilary has worked in the patent profession for most of her career in an administrative role, gaining her CIPA qualification in 2008. Hilary has an extensive knowledge of patent prosecution throughout the UK, EPC, and PCT territories, together with overseeing foreign filings worldwide.

marie young copy.jpg

mARIE LAYZELL

SENIOR RESEARCH MANAGER

Marie has over 18 years’ experience as an analytical scientist and project manager in the pharmaceutical industry. Following a career as an analytical scientist and project supervisor, Marie spent 5 years as an analytical consultant. She joined Small Pharma in 2016 to lead CMC development.

Tiff 2a circle.jpg

TIFFANIE BENWAY

RESEARCH ANALYST

Tiffanie graduated from Skidmore College, NY, in 2008 with a degree in Neuroscience, before moving to UCL to complete her MSc and PhD in the same field. Tiffanie joined Small Pharma in 2017 to support nonclinical development, with a focus on experimental design..

Ellen copy.jpg

Ellen James

SENIOR RESEARCH MANAGER

Ellen has 12 years’ experience in research, development and clinical project management. Following a PhD and post-doc at Imperial College London, Ellen managed the development programmes for 2 NCEs at Trio Medicines, as well as managing several early phase clinical trials.

Barry 2a.jpg

BARRY KNIGHT

CHIEF FINANCIAL OFFICER

Barry has more than 25 years’ experience as an executive director in rapidly growing life sciences businesses including CFO at Domainex Ltd, COO at Kinapse Ltd and Finance Director at AIM-listed Fulcrum Pharma plc. Barry is currently also CFO at Edinburgh Molecular Imaging Ltd.